CN Patent
CN113727758A — 双环杂环基化合物及其用途
Assigned to Ruixin Pharmaceutical Co · Expires 2021-11-30 · 4y expired
What this patent protects
本发明针对SOS1调节剂及其用于治疗疾病的用途。还公开了包含所述SOS1调节剂的药物组合物。
USPTO Abstract
本发明针对SOS1调节剂及其用于治疗疾病的用途。还公开了包含所述SOS1调节剂的药物组合物。
Drugs covered by this patent
- Xalkori (crizotinib) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.